• 23/02/2017

    Behind the Scenes at MDR-TB Enrollment in Kyrgyzstan and Tajikistan

    Since the end of last year, KNCV and partners have been enrolling patients with multi-drug resistant-TB (MDR-TB) in…

    Lees meer
  • 17/02/2017

    The End of an Era: Symposium to celebrate the work of Dr. Maarten van Cleeff

    On Friday, February 17th, USAID and KNCV organized a symposium to celebrate Maarten van Cleeff’s role in the global fight…

    Lees meer
  • 13/02/2017

    International Meeting Week 2017

    Today marks the start of this year’s KNCV International Home Week, a week where KNCV experts, consultants and advisors from…

    Lees meer
  • 09/02/2017

    Announcement new CTB Director Dr. Gidado Mustapha

    We are very pleased and proud to announce that Dr. Gidado Mustapha M.B.B.S, MPH, MSc., has been selected…

    Lees meer
  • 07/02/2017

    Challenge TB Annual Report out now

    Challenge TB is the global flagship mechanism of the United States Agency for International Development (USAID) to prevent and control…

    Lees meer
  • 13/01/2017

    Roundtable ‘Health across borders’

    January 13, 2017 the Netherlands Institute of International Relations Clingendael and KNCV Tuberculosis Foundation are co-hosting a policy-maker roundtable ‘Health…

    Lees meer
  • 12/01/2017

    The first MDR-TB patients enrolled on shorter and better treatment in Tajikistan and Kyrgyzstan

    Just before the turn of the year, new hope was provided for MDR-TB patients in Tajikistan. The first patients were…

    Lees meer
  • 12/01/2017

    Launch of the official commencement of activities in the Philippines

    KNCV and HIVOS are proud to announce the official commencement of activities in the Philippines as…

    Lees meer
  • 16/12/2016

    High-Level Meeting on TB announced

    KNCV highly welcomes the news that the United Nations General Assembly has agreed to hold a High-Level Meeting (HLM) on…

    Lees meer
  • 16/12/2016

    Prevalence surveys for the modern age

    How can you solve a problem without clearly knowing what the problem is? Understanding the TB-epidemic, specifically within national borders,…

    Lees meer
  • 16/12/2016

    A look back at the Union Conference 2016

    From the 26th to the 29th of October, Liverpool was host to the 47th annual conference on lung health. As…

    Lees meer
  • 16/12/2016

    Patient Support Groups

    The last edition of KNCV Update addressed the issue of stigma that TB patients, and especially MDR-TB patients,…

    Lees meer
  • 16/12/2016

    Putting numbers on the End TB Strategy—an impossible dream?

    A unique international collaboration consisting of 11 different tuberculosis modelling groups, as well as public health officials from NTPs has…

    Lees meer
  • 12/12/2016

    Universal Health Coverage Day

    What is UHC? Globally, 400 million people lack access to one or more essential health…

    Lees meer
  • 10/11/2016

    One of the best things of this year is that I was able to meet so many dedicated people

    Kristian van Kalmthout – former Young Professional at KNCV In 2011 Kristian graduated Maastricht University with a master degree in…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.